Skip to nav Skip to content

CDC/IDSA COVID-19 Clinician Call: Antibody Therapy & Second Boosters: Updates and Perspectives on Protecting Our Most Vulnerable

Facebook Twitter LinkedIn Email

To Download a copy of the presentation click here.

To Download a copy of the Q&A Responses here.

Topic: Antibody Therapy & Second Boosters: Updates and Perspectives on Protecting Our Most Vulnerable

Moderator:
Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA

Update: New Resources to Manage Paxlovid Drug Interactions
Carlos del Rio, MD, FIDSA
President-Elect, IDSA
Distinguished Professor of Medicine, Division of Infectious Diseases
Emory University School of Medicine
Professor of Epidemiology & Global Health
Rollins School of Public Health of Emory University

Topics and Featured Experts:

Prevention of COVID-19 in Immunocompromised Individuals: Focus on Evusheld
Clinical Considerations & Patient Scenarios
Camille Kotton, MD, FIDSA, FAST
Clinical Director
Transplant & Immunocompromised Host Infectious Diseases
Massachusetts General Hospital

Utilization Update & Strategies to Improve Access
Derek Eisnor, MD
Medical Officer, Division of Clinical Development
Biomedical Advanced Research and Development Authority
COVID-19 Allocation and Distribution Lead
U.S. Department of Health & Human Services

Lessons Learned and Success Stories
Swana K. Thomas, PharmD, MPH
Clinical Pharmacist, Ambulatory Care
Geisinger Health System

Monoclonal Antibody Therapy for Treatment: What are the Options?
Raymund R. Razonable, MD
Professor of Medicine
Vice Chair, Infectious Diseases
Mayo Clinic

Second Boosters: Who Will Benefit?
Updates & Clinical Considerations from the April 20 ACIP Meeting
Elisha Hall, PhD, RD
Lead, Clinical Guidelines
Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention

Perspectives on the Immunocompromised & People Over 50
William Schaffner, MD
Professor of Preventative Medicine, Department of Health Policy
Professor of Medicine, Division of Infectious Diseases
Vanderbilt University School of Medicine

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.